Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,349,807,890
-$2,004,893,018 QoQ
Shares Held
13,427,061
+0.5% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
2.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 96.77652466165158.ToString("F0")%
None 3.223475338348429.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $38,477,015,517 across 12 Drug Manufacturers - General names. LLY ranks #1 (32.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
13,427,061 | $12,349,807,890 | |
| 2 | MRK |
Merck & Co., Inc.
|
84,314,971 | $10,142,247,857 | |
| 3 | JNJ |
Johnson & Johnson
|
20,075,375 | $4,907,224,662 | |
| 4 | AZN |
Astrazeneca PLC
|
23,751,085 | $4,684,188,978 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,537,991 | $1,886,789,800 | |
| 6 | ABBV |
AbbVie Inc.
|
6,897,816 | $1,500,205,997 | |
| 7 | PFE |
Pfizer Inc
|
49,916,961 | $1,401,668,262 | |
| 8 | GSK |
GSK plc
|
11,717,613 | $646,695,059 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,349,807,890 | 13,427,061 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,354,700,908 | 13,357,185 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,112,164,140 | 14,563,780 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,905,274,687 | 13,989,551 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,495,261,231 | 12,707,512 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,747,214,100 | 12,625,925 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,403,186,424 | 10,613,796 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,759,173,405 | 10,779,091 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,570,106,157 | 11,016,127 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,866,696,167 | 11,779,826 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $6,904,518,780 | 12,854,465 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,777,374,890 | 14,451,309 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,979,759,767 | 20,324,267 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,320,428,397 | 20,009,918 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,063,027,171 | 21,843,288 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,599,061,507 | 23,437,256 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,795,942,146 | 27,223,320 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,536,465,750 | 27,284,287 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,557,676,346 | 28,382,066 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,007,284,154 | 30,530,168 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,938,817,052 | 31,788,979 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,596,767,748 | 33,148,352 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,747,546,968 | 25,317,842 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,431,345,926 | 26,990,778 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,997,180,888 | 36,023,507 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||